You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Serbia

Oct 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Serbia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Serbia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Serbia for free:

The Consumer Health in Serbia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Serbia?
  • What are the major brands in Serbia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Increased health awareness and willingness to self-medicate boost sales

The review period saw growing demand for consumer health in Serbia. This trend was supported by a number of factors, including improved living standards and better education in general and with regards to health and wellness. Consumers thus became increasingly willing to self-medicate. There was also a rapid increase in the range of products on offer in consumer health, as more foreign producers entered following liberalisation in 2001. Meanwhile, there was rapid expansion in retailing during the review period, including chemists/pharmacies and parapharmacies/drugstores. This resulted in consumer health becoming more accessible to Serbian consumers, particularly in rural areas.

Growth slows due to economic downturn

Sales growth notably slowed towards the end of the review period due to the impact of the economic downturn. Serbia saw a marked drop in real GDP and in remittances in 2009, with only a slight recovery in 2010. Consumers were meanwhile faced by high inflation and declining disposable income levels. Consequently, many consumers were forced to cut back on their spending on consumer health, with many product areas thus seeing weaker current value growth in the year.

Affordable domestic and regional players gain share

The impact of the economic downturn could clearly be seen on company shares in consumer health at the end of the review period. Affordable domestic players consequently mainly gained share in 2010 over the previous year. The leading player in 2010 was state-owned Galenika, which benefits from offering good quality products at low prices. This company thus saw the strongest growth in value share in the year. Affordable regional players also gained share, such as Alkaloid from Macedonia.

Retailing sees rapid development

The Serbian retailing industry saw rapid development during the review period, with the number of outlets selling consumer health dramatically increasing. There was particularly strong growth in the number of privately-owned chemists/pharmacies, beauty specialist retailers and supermarkets/hypermarkets during the review period. Retailing expansion was thus a key factor behind good current value growth in consumer health, particularly driving sales growth in rural areas as consumers’ access to these products improved. In addition, growing competition in the retailing of these products increased price competition within consumer health and resulted in many products becoming more affordable.

Good forecast period growth thanks to ageing population

Serbia’s ageing population is expected to support strong growth for consumer health during the forecast period. The country’s consumer base is also expected to become more sophisticated in its understanding of health problems and their treatment, with growing media coverage of health and wellness in the country. Consumers are thus likely to become more willing to self-medicate. This trend is likely to be encouraged by further expansion in the number of chemists/pharmacies and parapharmacies/drugstores across the country and by these outlets offering a wider range of consumer health.

Table of Contents

Table of Contents

Consumer Health in Serbia - Industry Overview

EXECUTIVE SUMMARY

Increased health awareness and willingness to self-medicate boost sales

Growth slows due to economic downturn

Affordable domestic and regional players gain share

Retailing sees rapid development

Good forecast period growth thanks to ageing population

KEY TRENDS AND DEVELOPMENTS

Retailing expansion improves consumer access

Serbian population ages and declines

End of government price controls on OTC

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Serbia - Company Profiles

Hemofarm ad in Consumer Health (Serbia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 4 Hemofarm ad: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 5 Hemofarm ad: Competitive Position 2010

Ivancic i Sinovi doo in Consumer Health (Serbia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Ivancic i Sinovi doo: Competitive Position 2010

Jugoremedija ad in Consumer Health (Serbia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Jugoremedija ad: Competitive Position 2010

Adult Mouth Care in Serbia - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care saw only slow current value growth in 2010, with sales mainly being boosted by inflation. Due to the impact of the economic downturn, some consumers cut back on the use of these products. By 2010, consumers typically use these products only when they have a mouth infection and adult mouth care is recommended by a doctor or a pharmacist. These products were thus rarely used for minor mouth ulcers.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leader in adult mouth care is domestic player Jugoremedija with its brand Cliacil. This brand accounted for 23% value share in 2010 and has been the leading brand in adult mouth care for more than a decade. The brand is positioned as curing most mouth infections and the majority of pharmacists and doctors routinely recommend Cliacil. The brand is positioned similarly to Galenika’s Aciklovir and Hemofarm’s Nystatin, which are Cliacil’s main competitors.

PROSPECTS

  • Easy-use products are expected to gain share during the forecast period, such as Fitosept Oriblete and Tantum Verde. These international brands are expected to gain share from popular domestic brands thanks to their convenience and rapid effect. Younger consumers increasingly prefer easy-use and instant remedies and are thus turning away from older brands. This trend is also expected to be encouraged by Serbia’s economic recovery, particularly towards the end of the forecast period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Serbia - Category Analysis

HEADLINES

TRENDS

  • Analgesics has been among the most popular product areas in consumer health in Serbia for decades, with these products being used by all age and income groups. These are the most common medicines to be found in Serbian households, being used for a wide range of mild health issues. Consequently, analgesics benefited strongly from a growing consumer confidence in self-medication. Growth was also spurred by growing consumer awareness of child-specific systemic analgesics and topical analgesics/anaesthetic.

SWITCHES

COMPETITIVE LANDSCAPE

  • Galenika is a long-established Serbian medicine producer and led sales of analgesics throughout the review period, accounting for 38% value share in 2010. The company benefits from offering the brands Brufen in ibuprofen, Anbol in aspirin and Paracetamol in acetaminophen, with these having been well accepted among middle-aged and older consumers for many decades. The company offers a wide range of analgesics, however, with this also including stomach-friendly Acetisal pH 8 in aspirin, Diklofen in a range of strengths in diclofenac, Defrinol in child-specific ibuprofen and Brufen and Diklofen brand extensions in topical analgesics/anaesthetic.

PROSPECTS

  • There is expected to be growing interest in niche product areas during the forecast period, as many consumers trade up in search of more effective analgesics. The bulk of sales will continue to be accounted for by economy products from lower-priced product areas. However, widening distribution and increasing consumer sophistication will boost sales for products such as child-specific analgesics and naproxen.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Serbia - Category Analysis

HEADLINES

TRENDS

  • From 2002 onwards, the Serbian Ministry of Health introduced more rigorous controls over Rx calming and sleeping products. The government imposed heavier fines on pharmacists selling Rx products under-the-counter and also required prescriptions to be endorsed by an additional second doctor. These measures were taken in response to the widespread abuse of Rx calming and sleeping products, with some consumers having used strong Rx products such as Bensendin without a doctor’s prescription for many years.

SWITCHES

COMPETITIVE LANDSCAPE

  • Lek is the leading player in calming and sleeping products and accounted for 8% value share in 2010. This company offers Persen in Serbia on behalf of multinational player Novartis. Persen gained popularity among Serbian consumers in 2002-2003 as a replacement for Rx products, following tighter controls on Rx sales. Persen is thus a synonym for OTC calming and sleeping products among many consumers and also among many pharmacists and doctors. The brand consequently benefits from frequent recommendations as effective stress relief.

PROSPECTS

  • Calming and sleeping products is expected to continue to see rapid expansion over the forecast period with a constant value CAGR of 6%. A growing number of Serbian consumers are expected to start to use these products, partly due to ongoing economic concerns at the start of the forecast period. Strict controls on under-the-counter sales of Rx products will also continue to support strong sales growth for Rx products.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Serbia - Category Analysis

HEADLINES

TRENDS

  • 2009 saw strong growth for cough, cold and allergy (hay fever) remedies due to the AH1N1 epidemic. Products such as combination products and cough remedies benefited in this year by many consumers using them as a preventative measure against flu, thus seeing 24% and 23% current value growth respectively in 2009. However, 2010 saw sales growth plummet in these areas as the panic subsided, with combination products seeing only 1% current value growth in 2010 and cough remedies growing by just 6%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Zdravlje-Leskovac, which is owned by Icelandic company Actavis, is the leader in Serbian cough, cold and allergy (hay fever) remedies and accounted for 18% of value in 2010. The company’s Fitosept range is very familiar to most Serbian consumers due to having been present in the country for decades. The company however lost share slightly in 2010 over the previous year as it struggled to match the strong marketing support offered by other multinationals such as GlaxoSmithKline and Bristol-Myers Squibb.

PROSPECTS

  • Demand for child-specific cough, cold and allergy (hay fever) remedies is expected to rise over the forecast period. Growth will be supported by growing awareness of these products’ gentle effect and a growing interest in child-specific consumer health in general, with this underpinning 5% constant value CAGR for child-specific cough/cold remedies. Growth is also expected to be driven by strong new product development in this product area. 2010 saw the entry of Nasya kids, which is expected to spur strong growth in child-specific allergy remedies and result in this product area gaining significant sales during the forecast period.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Serbia - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies suffered from the impact of the economic downturn at the end of the review period. Increased price-sensitivity resulted in many consumers switching from packaged to home-made digestive remedies towards the end of the review period, with this trend impacting product areas such as laxatives and diarrhoeal remedies. In addition, consumers spent less on food and drink, with a shift away from richer food and alcoholic drinks also resulting in less demand for digestive remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • Zdravlje-Leskovac offers popular brand Ranisan in H2 blockers on behalf of Actavis Group. The company is thus the leading player in digestive remedies, with Ranisan alone accounting for 20% value share in 2010. The company’s other leading brand is Loperamid in diarrhoeal remedies, with both brands benefiting from strong distribution, widespread consumer awareness and effective marketing support. Ranisan is commonly-recommended in chemists/pharmacies and parapharmacies/drugstores for those suffering from indigestion and heartburn. Overall, Zdravlje-Leskovac accounted for 30% value share in 2010.

PROSPECTS

  • Growth is expected to be muted for digestive remedies during the forecast period. Sales growth is likely to remain low due to consumers’ economic uncertainty, with many opting for lower-priced or home-made remedies as a result. In addition, there is likely to be growing awareness of the causes of digestive disorders during the forecast period. Consequently, many consumers will seek to improve their digestion by eating healthier diets, observing stricter levels of hygiene and supplementing their diets with pro/pre biotic dairy products.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Serbia - Category Analysis

HEADLINES

TRENDS

  • There was little activity within ear care towards the end of the review period. Players invested little in promoting these products and there was a lack of new product development. Sales are dominated by two brands: Galenika’s Hydrocyclin and Hemofarm’s Otol H, which have been present for many years. This lack of competitive activity hindered sales growth, with current value growth thus mainly being driven by a growing consumer willingness to self-medicate and by inflation.

SWITCHES

COMPETITIVE LANDSCAPE

  • Galenika leads ear care, with its Hydrocyclin brand accounting for 36% value share in 2010. This brand is widely recognised by pharmacists and doctors, both reducing inflammation and containing antibiotics that tackle a wide range of bacterial ear infections. Those consumers who self-medicate are also most likely to choose this brand, as it has been present in Serbia for decades and thus enjoys the strongest consumer awareness within ear care.

PROSPECTS

  • Serbian ear care is not expected to see dramatic changes during the forecast period in terms of increased demand, premiumisation or new entrants. Value sales growth will instead be driven mainly by inflation. However, slow volume growth of around 1-2% a year will also be supported by increased health awareness and a growing willingness to self-medicate. Rural sales growth will also be supported by expansion in the number of chemists/pharmacies and parapharmacies/drugstores in these areas, with this making ear care more accessible.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Serbia - Category Analysis

HEADLINES

TRENDS

  • Serbian eye care was constrained by a lack of player investment at the end of the review period. There was little activity in terms of new product development or in terms of marketing. Value sales growth was thus mainly caused by increased current value prices due to inflation rather than volume growth or premiumisation. Sales however benefited from increased health-awareness among Serbian consumers and a growing willingness to self-medicate.

SWITCHES

COMPETITIVE LANDSCAPE

  • Galenika dominates eye care sales and accounted for 53% value share in 2010. The company’s Chloramphenicol is among the brands most recommended by doctors and pharmacists as it cures most mild eye problems and tackles a wide spectrum of bacteria. Chloramphenicol has been present in Serbia for decades. Many consumers suffering from long-term mild eye problems consequently purchase this product themselves without any previous consultation with a doctor or pharmacist.

PROSPECTS

  • Eye care is not expected to see dramatic changes during the forecast period. The leading brands are expected to remain strong during the forecast period, benefiting from a long history in the country and a high degree of customer loyalty. However, sales growth is likely to be constrained by consumer price-sensitivity at the start of the forecast period. Overall, eye care is thus expected to see a slow constant value CAGR of 2% during the forecast period.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Serbia - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products benefited from two main trends at the end of the review period. Firstly, these products benefited from their natural image. There was a growing health-awareness in the country during the review period, with consumers becoming increasingly concerned about the side effects associated with standard products. In addition, many herbal/traditional products also benefited from low prices, which attracted consumers in the wake of the economic downturn.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products is extremely fragmented, with “others” accounting for 89% value share in 2010. This is due to a large number of product categories and also due to a large number of small domestic products. “Others” further gained over half a percentage point in value share in 2010 over the previous year, while all leading players either lost share or stagnated. This was due to parapharmacies/drugstores and chemists/pharmacies offering a wider range of products and brands.

PROSPECTS

  • Sales of herbal/traditional products are expected to benefit from the health and wellness trend during the forecast period. Consumers are expected to increasingly question the side effects associated with standard medicines. In addition, there is expected to be increasing trust in the efficacy and safety of herbal remedies.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Serbia - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care suffered due to the crisis in Serbia in 2010, due to the cosmetic positioning of many products. Many consumers cut back on their purchase of products such as acne treatments, medicated shampoos and hair loss treatments, regarding these products as non-essential. There was also a shift from topical germicidals/antiseptics and nappy (diaper) rash treatments to cheaper home-made alternatives, such as alcohol and chamomile tea. 2010 thus saw visibly slower current value growth at 3% in comparison to a review period current value CAGR of 13%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Beiersdorf leads sales of medicated skin care thanks to its Nivea Baby brand in nappy (diaper) rash treatments. The company led sales throughout the review period and accounted for 33% value share in 2010. Nivea is an extremely popular skin care brand in Serbia, having been present for decades and entering before most other foreign.

PROSPECTS

  • Slow economic recovery during the forecast period is expected to boost sales for medicated skin care. Many of these products are widely regarded as non-essential, with this perception hindering sales growth for products such as acne treatments and medicated shampoos. Consequently, sales growth is expected to benefit from rising disposable income levels. Growth is also expected to be supported by greater competition during the forecast period, with both players and retailers likely to compete for share by focusing on offering low prices and strong marketing support.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Hair Loss Treatments Brand Shares 2007-2010
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Serbia - Category Analysis

HEADLINES

TRENDS

  • On 11 November 2010, Serbia introduced the Law of Protection from Tobacco Smoke. This tough legislation banned smoking inside and outside all government buildings and in schools, social care institutions, building used for cultural or sporting activities and media buildings. Smoking is banned in all enclosed public spaces and work spaces as well as many on-trade outlets and in open air theatres and cinemas. Smaller bars and cafes may decide if they wish to be smoke-free or not, while larger on-trade outlets must provide a non-smoking area that occupies more than half of the premises and is properly ventilated. Fines for non-compliance are high, ranging from RSD5,000 upwards.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson’s Nicorette Freshmint is the only product available in NRT smoking cessation aids in Serbia. This lack of competition constrained growth at the end of the review period. There is little pressure on Johnson & Johnson to offer attractive prices or to invest in strong advertising support, due to the company’s monopoly within NRT smoking cessation aids.

PROSPECTS

  • The introduction of the smoking ban in 2010 is expected to result in a further decline in the smoking population during the forecast period. This legislation is expected to be rigorously enforced as Serbia seeks EU membership. The government is also expected to further increase taxes on all tobacco products over the forecast period. Overall, the number of smokers in Serbia is expected to drop to 1.5 million by 2015, down by 13% during the forecast period. The smoking population is thus set to decline to below 27% of the overall population. A growing number of smokers will seek to quit smoking, spurred by the smoking ban and by growing health-awareness in the country.

CATEGORY INDICATORS

  • Table 67 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 68 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 69 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 70 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 71 NRT Smoking Cessation Aids Company Shares 2006-2010
  • Table 72 NRT Smoking Cessation Aids Brand Shares 2007-2010
  • Table 73 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Serbia - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition suffered from an extremely narrow target group throughout the review period. These products are only used regularly by bodybuilders. Most Serbian consumers view sports nutrition as dangerous, with many confusing these products with illegal steroids. Even those who are aware of the distinction between sports nutrition and steroids are concerned by these products’ rapid impact on the human body. Many sports nutrition users indeed agree that these products are unhealthy, although they are willing to use them in order to rapidly reach their sporting or fitness goals.

COMPETITIVE LANDSCAPE

  • There were no visible leaders in Serbian sports nutrition at the end of the review period, with shares being highly fragmented. A number of companies have a presence in most specialised sports nutrition stores, however. These include Twinlab Corp, Ultimate Nutrition, Universal Nutrition, Bio Tech Nutrition, Dymatize and Medical Pharma.

PROSPECTS

  • Exercise trends are changing in Serbia, which is likely to pose a major challenge to sports nutrition during the forecast period. At the start of the 2000s, bodybuilding was a mainstream gym activity and many men in particular visited gyms regularly aiming to increase their muscle mass and shape their bodies. To reach this goal, many bodybuilders were encouraged to use sports nutrition by gym owners or close friends.

CATEGORY DATA

  • Table 75 Sports Nutrition, category rankings 2010
  • Table 76 Sales of Sports Nutrition: Value 2005-2010
  • Table 77 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 78 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 79 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 80 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Serbia - Category Analysis

HEADLINES

TRENDS

  • Sales benefited from widening distribution for vitamins and dietary supplements towards the end of the review period. Supermarkets and hypermarkets notably saw 43% and 36% current value growth respectively in 2010 thanks to widening their ranges. Consumers thus gained better access to vitamins and dietary supplements, while there was also a strong 19% current value growth in internet retailing sales at the end of the review period. Consumers increasingly explored the wider range of vitamins and dietary supplements available online.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • CaliVita International is leader in Serbian vitamins and dietary supplement market in 2010. This company came to the market at the beginning of the previous decade when Serbian VDS market was extremely undeveloped. In a short time, this company succeeded to cover significant market share of Serbian VDS market to reach 67% in 2010.

PROSPECTS

  • Growing health-awareness is expected to support sales growth during the forecast period. The Serbian media is expected to become increasingly focused on health and wellness stories and will cover the latest trends and health claims in this area. Consumers are also likely to become more interested in health and wellness due to the ageing population with a growing number willing to invest in preserving their energy levels and youth.

CATEGORY DATA

  • Summary 12 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 81 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 82 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 83 Dietary Supplements by Positioning 2006-2010
  • Table 84 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 85 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 86 Vitamins Brand Shares 2007-2010
  • Table 87 Dietary Supplements Brand Shares 2007-2010
  • Table 88 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Serbia - Category Analysis

HEADLINES

TRENDS

  • Weight management saw growing interest in Serbia towards the end of the review period. This was due to consumers increasingly focusing on their appearance, with a growing association between slimness and health and social success. Many took western European and US celebrities and models as inspiration and aspired to lose weight in order to look more like them. Growing interest in staying slim was thus driven more by consumers seeking to look slim and attractive, rather than by a sharp rise in obesity and overweight in the country.

COMPETITIVE LANDSCAPE

  • Biomed was the leader in weight management in 2010 with 21% value share. This company has been well-known among Serbian consumers from the 1990s onwards, when it introduced Biomed 4. This is the leading meal replacement slimming brand and accounted for 29% value share in 2010, while ranking second in weight loss supplements with 22% value share. Biomed also offers White Tiger energy bars in meal replacement slimming. Thanks to strong advertising, Biomed also saw the strongest growth in value share in 2010 over the previous year, gaining almost a percentage point.

PROSPECTS

  • Weight management is expected to see fast growth over the forecast period. There is expected to be an upsurge in demand among younger people, with a growing focus on Western European and US celebrities and a growing focus on looking slim and fashionable. This trend is expected to be especially strong among the female population aged 16-40-years-old.

CATEGORY DATA

  • Table 90 Sales of Weight Management by Category: Value 2005-2010
  • Table 91 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 92 Weight Management Company Shares 2006-2010
  • Table 93 Weight Management Brand Shares 2007-2010
  • Table 94 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 95 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Serbia - Category Analysis

HEADLINES

TRENDS

  • Wound care saw growth rates drop towards the end of the review period, as the economic downturn resulted in many consumers buying these products only when needed. There was also a shift towards cheaper products, with first aid kits notably seeing current value growth plummet to 2% in 2010. Instead, many consumers opted for cheap bandages. As a result, current value sales rose by just 6% in 2010 over the previous year in comparison to a review period current value CAGR of 12%.

COMPETITIVE LANDSCAPE

  • 45% of value sales in Serbian wound care were accounted for by Galenika in 2010. This company offers products across wound care, including first aid kits, sticking plasters/adhesive bandages and gauze, tape and “other” wound care. The company has been present in wound care for decades and has the strongest distribution across the country. Galenika ad is still managed by the government and enjoys strong consumer confidence.

PROSPECTS

  • Growth rates in wound care are expected to remain muted at the start of the forecast period. Ongoing economic uncertainty will result in consumers continuing to opt for economy options within wound care, particularly bandages. As a result of this trend, wound care is expected to see only slow growth during the forecast period, with a constant value CAGR of 3%.

CATEGORY DATA

  • Table 96 Sales of Wound Care by Category: Value 2005-2010
  • Table 97 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 98 Wound Care Company Shares 2006-2010
  • Table 99 Wound Care Brand Shares 2007-2010
  • Table 100 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 101 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

      RELATED

      Consumer Lifestyle

      Future Demographic

      Country Report